Stanford Investment Group’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-202
Closed -$5K 203
2016
Q4
$5K Sell
202
-202
-50% -$5.62K ﹤0.01% 333
2016
Q3
$11K Hold
404
0.01% 310
2016
Q2
$10K Buy
404
+101
+33% +$2.87K 0.01% 299
2016
Q1
$10K Hold
303
0.01% 294
2015
Q4
$9K Hold
303
﹤0.01% 275
2015
Q3
$10K Hold
303
0.01% 275
2015
Q2
$15K Sell
303
-11
-4% -$464 0.01% 259
2015
Q1
$14K Buy
+314
New +$11.3K 0.01% 264

Other funds holding PGEN

Stanford Investment Group's PGEN Position: Q1 2017 in Review

Stanford Investment Group sold out of Precigen (PGEN) in Q1 2017, closing a stake of 202 shares — an estimated $5K sold.

Stanford Investment Group first reported a position in PGEN in Q1 2015 and held it in 8 quarters. The position peaked at $15K in Q2 2015. 154 funds tracked by Wall St. Rank hold PGEN as of Q1 2017.

  • Stanford Investment Group reported no remaining Precigen position as of Q1 2017 after selling out during the quarter.
  • Stanford Investment Group sold 202 Precigen shares in Q1 2017, an estimated $5K.
  • Stanford Investment Group first reported a position in Precigen in Q1 2015 and held it in 8 quarters.
  • Stanford Investment Group's Precigen position peaked at $15K in Q2 2015.
  • 154 funds tracked by Wall St. Rank held Precigen as of Q1 2017.

Based on Stanford Investment Group's 13F filing for Q1 2017.